严重急性呼吸道综合征冠状病毒2(SARS-CoV-2)是一种新发现的人体内冠状病毒株,于2019年底在武汉报道。到目前为止,疫情仍在持续,而且非常严重,随着感染和死亡人数的增加。尽管世界各地进行了积极的调查,以更好地了解传播的动态和临床疾病的范围,COVID-19继续在人与人之间迅速传播。SARS-CoV-2感染的常见体征和症状包括发烧,疲劳,干咳,和呼吸困难;在严重的情况下,患者可能患有急性呼吸窘迫综合征,感染性休克,代谢性酸中毒难以治疗和凝血障碍。然而,一些呼吸道SARS-CoV-2检测呈阳性的患者可能没有此类临床体征和症状。本报告对太原市第四人民医院收治的一例患者进行了个案研究分析,他因车祸受伤,并以胸腔积液为首发症状,在COVID-19中幸存下来。我们报告了一例以胸腔积液为首发症状的2019-NCOV。详细描述鉴别诊断,诊断,临床管理,和治愈这种情况。为了在打击小说冠状病毒的过程中提供教训和帮助。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly identified strain of coronavirus in the human body and was reported in Wuhan at the end of 2019. So far, the epidemic is continuing and very serious, with the number of infections and deaths increasing. Despite active investigations around the world to better understand the dynamics of transmission and the scope of clinical disease, COVID-19 continues to spread rapidly from person to person. The common signs and symptoms of SARS-CoV-2 infection include fever, fatigue, dry cough, and dyspnea; in severe cases, patients may have acute respiratory distress syndrome, septic shock, metabolic acidosis difficult to treat and coagulation disorder. However, some patients who test positive for SARS-CoV-2 in their respiratory tract may not have such clinical signs and symptoms. This report presents a
case study analysis of a patient admitted in the Fourth Taiyuan People\'s Hospital, who had suffered traumatic injuries from a car accident and survived COVID-19, with pleural effusion as the initial symptom. We report a
case of 2019-NCOV with pleural effusion as the first symptom. Describe in detail the differential diagnosis, diagnosis, clinical management, and cure of this
case. In order to combat the novel CoronaviruscoVID-19 in the process to provide lessons and help.